Latest Company Risk News

Page 1 of 1
Adore Beauty has cut FY27 underlying EBITDA guidance by more than half after distribution centre disruption and weak consumer demand hit first-half trading. The company has withdrawn revenue guidance and begun cash flow measures while discussing covenant compliance with its bank.
Logan Eniac
Logan Eniac
16 Nov 2026
ImpediMed has secured A$15.2 million through a two-tranche placement and share purchase plan, alongside A$5 million in cost reductions, aiming for operating cashflow breakeven by H2 FY28.
Ada Torres
Ada Torres
4 May 2026
Global Uranium and Enrichment Limited (GUE) has registered its scheme booklet with ASIC, detailing the proposed acquisition by Snow Lake Resources Ltd. The independent expert report supports the fairness and reasonableness of the deal, with GUE directors unanimously recommending shareholder approval.
Maxwell Dee
Maxwell Dee
22 Dec 2025
Resouro Strategic Metals has raised CAD$1 million through the first tranche of a private placement, advancing its Tiros Titanium-Rare Earths Project in Brazil. The company plans to use the funds to progress engineering work ahead of a Preliminary Economic Assessment.
Maxwell Dee
Maxwell Dee
21 Oct 2025
Paterson Resources has announced a $2 million capital raising via a placement and a non-renounceable entitlement offer, aimed at advancing its Grace Project in Western Australia. The offer includes new shares priced at $0.018 each and free attaching options, with proceeds earmarked for drilling, studies, and working capital.
Maxwell Dee
Maxwell Dee
26 Sept 2025
Alterity Therapeutics reported a reduced net loss of A$12.15 million for FY2025, buoyed by positive Phase 2 clinical trial results for its lead drug ATH434 in Multiple System Atrophy and a successful A$40 million capital raising.
Ada Torres
Ada Torres
29 Aug 2025
The Federal Court of Australia has dismissed Harvey Norman’s appeal against prior legal declarations, setting the stage for an upcoming penalty hearing that could impact the retailer’s future.
Logan Eniac
Logan Eniac
28 Aug 2025
NAOS Ex-50 Opportunities Company Limited (ASX, NAC) reported a strong turnaround with a $7.55 million profit after tax for FY25 and a 28.9% portfolio return, declaring a 1.5 cent per share dividend. The company’s focused investments in emerging Australian and New Zealand companies underpin its robust performance and disciplined capital management.
Claire Turing
Claire Turing
21 Aug 2025
Syrah Resources has initiated a fully underwritten A$70 million equity raising alongside a two-year forbearance agreement with the US Department of Energy, supporting its Vidalia and Balama operations. The retail entitlement offer opened on 6 August and closes on 20 August 2025.
Maxwell Dee
Maxwell Dee
6 Aug 2025
Vitrafy Life Sciences announces a leadership change with CEO Kate Munnings retiring and co-founder Brent Owens stepping up to lead the company’s next growth phase.
Ada Torres
Ada Torres
5 Aug 2025
Marimaca Copper Corp. has issued a prospectus for a nominal cleansing offer of 100 new CDIs at A$10.65 each, aiming to remove trading restrictions on previously issued securities. The company also disclosed extensive risk factors, including ongoing legal proceedings and project development uncertainties.
Maxwell Dee
Maxwell Dee
15 July 2025

Browse the archive

Full archive